Tenet Healthcare Corporation $THC Stock Sold by First Eagle Investment Management LLC

First Eagle Investment Management LLC cut its stake in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 51.1% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 8,938 shares of the company’s stock after selling 9,328 shares during the period. First Eagle Investment Management LLC’s holdings in Tenet Healthcare were worth $2,284,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of THC. Aberdeen Group plc increased its stake in shares of Tenet Healthcare by 4,392.9% during the third quarter. Aberdeen Group plc now owns 845,555 shares of the company’s stock worth $216,090,000 after purchasing an additional 826,735 shares in the last quarter. Manning & Napier Advisors LLC acquired a new stake in Tenet Healthcare during the second quarter worth $168,761,000. Arrowstreet Capital Limited Partnership raised its position in Tenet Healthcare by 57.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock valued at $126,757,000 after purchasing an additional 244,901 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Tenet Healthcare during the second quarter worth about $106,342,000. Finally, Empowered Funds LLC lifted its holdings in Tenet Healthcare by 22.1% during the 1st quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock worth $53,736,000 after buying an additional 51,549 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Key Headlines Impacting Tenet Healthcare

Here are a few of the latest headlines about THC:

  • Positive Sentiment: Zacks Research raised its EPS forecasts across several quarters and full years. Its FY2027 estimate increased to $19.77 from $18.91, and its FY2028 estimate rose to $20.98 from $20.09. Higher analyst expectations may support investor sentiment by suggesting improved earnings prospects. Tenet Healthcare analyst estimates
  • Positive Sentiment: A separate Zacks article characterized THC as a top-ranked momentum stock, a potentially favorable signal for investors focused on price trends. Zacks momentum-stock article
  • Neutral Sentiment: Despite the estimate increases, Zacks Research maintained a “Hold” rating, indicating it did not make a more bullish recommendation. Tenet Healthcare analyst information

Tenet Healthcare Price Performance

THC stock opened at $263.34 on Friday. The business has a 50 day moving average price of $268.86 and a 200 day moving average price of $226.99. The stock has a market cap of $20.96 billion, a price-to-earnings ratio of 7.64, a PEG ratio of 1.56 and a beta of 1.20. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $301.44. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76.

Tenet Healthcare (NYSE:THC – Get Free Report) last announced its quarterly earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating the consensus estimate of $4.68 by $1.96. The company had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm’s revenue was up 6.5% on a year-over-year basis. During the same period in the prior year, the firm posted $3.70 earnings per share. Equities research analysts anticipate that Tenet Healthcare Corporation will post 22.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on THC. Zacks Research downgraded Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 29th. Royal Bank Of Canada raised their target price on shares of Tenet Healthcare from $283.00 to $304.00 and gave the company an “outperform” rating in a report on Monday, November 2nd. Stephens reiterated an “overweight” rating and set a $285.00 price target on shares of Tenet Healthcare in a report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Friday, October 2nd. Finally, Bank of America raised their price objective on shares of Tenet Healthcare from $290.00 to $295.00 and gave the company a “buy” rating in a report on Monday, August 10th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $296.65.

View Our Latest Stock Report on Tenet Healthcare

Insider Transactions at Tenet Healthcare

In related news, Director Richard Mark sold 10,000 shares of Tenet Healthcare stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the sale, the director directly owned 25,121 shares in the company, valued at $6,617,373.82. This trade represents a 28.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Lisa Foo sold 24,000 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares of the company’s stock, valued at approximately $2,144,674.96. This trade represents a 74.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 99,462 shares of company stock worth $27,081,234. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.

See Also

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.